Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-19-001577

President and CEO gave up 40,880 shares (to pay taxes)

  • President and CEO acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Culley Brian M President and CEO 2019-01-01 Option exercise +100,000 100,000 D: show line 1 in the form
Culley Brian M President and CEO 2019-01-01 Shares withheld for taxes −40,880 $0.91 $37,323 59,120 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Culley Brian M President and CEO 2019-01-01 Option exercise · Restricted Stock Units −100,000 0 D: show line 3 in the form
Loading xslF345X03/doc4.xml…